Cancer BiologyBloodPeer-reviewed
RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway activation
Madeline Y. Mayday, Giulia Biancon, Manyi Wei…·Diane S. Krause
This study shows that the RBM15-MKL1 fusion protein drives leukemia through m6A methylation and WNT pathway activation, with METTL3 inhibition reducing tumor growth.